Romina Moavero

Summary

Publications

  1. pmc Is mTOR inhibition a systemic treatment for tuberous sclerosis?
    Romina Moavero
    Systems Medicine Department, Child Neurology and Psychiatry Unit, Tor Vergata University Hospital of Rome, Via Montpellier 1, 00133, Rome, Italy
    Ital J Pediatr 39:57. 2013
  2. doi request reprint Clinical Reasoning: a girl presenting with stiffness episodes during sleep, cafe-au-lait spots, and flecked retina
    Romina Moavero
    Pediatric Neurology Unit, Neuroscience Department, Tor Vergata University Hospital, Rome
    Neurology 80:e42-6. 2013
  3. pmc The neurobiological basis of ADHD
    Paolo Curatolo
    Department of Neuroscience, Tor Vergata University of Rome, Italy
    Ital J Pediatr 36:79. 2010
  4. doi request reprint Rufinamide efficacy and safety as adjunctive treatment in children with focal drug resistant epilepsy: the first Italian prospective study
    Romina Moavero
    Pediatric Neurology Unit, Neuroscience Department, Tor Vergata University Hospital of Rome, Viale Oxford 81, 00133 Rome, Italy
    Epilepsy Res 102:94-9. 2012
  5. doi request reprint Long-term neurological outcome in children with early-onset epilepsy associated with tuberous sclerosis
    Raffaella Cusmai
    Division of Neurology, Bambino Gesu Children s Hospital, Rome, Italy
    Epilepsy Behav 22:735-9. 2011
  6. doi request reprint Early control of seizures improves long-term outcome in children with tuberous sclerosis complex
    Roberta Bombardieri
    Department of Neurosciences, Pediatric Neurology Unit, Tor Vergata University, Via Montpellier 1, Rome 00133, Italy
    Eur J Paediatr Neurol 14:146-9. 2010
  7. doi request reprint Attention-deficit hyperactivity disorder (ADHD) and tuberous sclerosis complex
    Elisa D'Agati
    Department of Neuroscience, Pediatric Neurology Unit, Tor Vergata University of Rome, Via Montpellier 1, 00133 Rome, Italy
    J Child Neurol 24:1282-7. 2009
  8. doi request reprint The management of subependymal giant cell tumors in tuberous sclerosis: a clinician's perspective
    Romina Moavero
    Neuroscience Department, Pediatric Neurology Unit, Tor Vergata University of Rome, Rome, Italy
    Childs Nerv Syst 27:1203-10. 2011
  9. doi request reprint Rufinamide for the treatment of refractory epilepsy secondary to neuronal migration disorders
    Raffaella Cusmai
    Division of Neurology, Bambino Gesu Children s Hospital, IRCCS, Rome, Italy
    Epilepsy Res 108:542-6. 2014
  10. doi request reprint Epilepsy secondary to tuberous sclerosis: lessons learned and current challenges
    Romina Moavero
    Department of Neuroscience, Pediatric Neurology Unit, Tor Vergata University of Rome, Via Montpellier 1, 00133, Rome, Italy
    Childs Nerv Syst 26:1495-504. 2010

Collaborators

Detail Information

Publications21

  1. pmc Is mTOR inhibition a systemic treatment for tuberous sclerosis?
    Romina Moavero
    Systems Medicine Department, Child Neurology and Psychiatry Unit, Tor Vergata University Hospital of Rome, Via Montpellier 1, 00133, Rome, Italy
    Ital J Pediatr 39:57. 2013
    ..Therefore, the positive effects that mTOR inhibition have on a wide variety of TSC disease manifestations make this a potential systemic treatment option for this genetic multifaceted disorder. ..
  2. doi request reprint Clinical Reasoning: a girl presenting with stiffness episodes during sleep, cafe-au-lait spots, and flecked retina
    Romina Moavero
    Pediatric Neurology Unit, Neuroscience Department, Tor Vergata University Hospital, Rome
    Neurology 80:e42-6. 2013
    ..She did not present any neurologic deficit, but she failed to develop an age-appropriate speech, with a delay in the main language milestones...
  3. pmc The neurobiological basis of ADHD
    Paolo Curatolo
    Department of Neuroscience, Tor Vergata University of Rome, Italy
    Ital J Pediatr 36:79. 2010
    ..Drug treatment should always be part of a comprehensive plan that includes psychosocial, behavioural and educational advice and interventions...
  4. doi request reprint Rufinamide efficacy and safety as adjunctive treatment in children with focal drug resistant epilepsy: the first Italian prospective study
    Romina Moavero
    Pediatric Neurology Unit, Neuroscience Department, Tor Vergata University Hospital of Rome, Viale Oxford 81, 00133 Rome, Italy
    Epilepsy Res 102:94-9. 2012
    ..Response to Rufinamide was not related to the age. Our experience suggests that Rufinamide can be effective in reducing focal seizure frequency in children with drug resistant epilepsy, and that it can be considered as a safe drug...
  5. doi request reprint Long-term neurological outcome in children with early-onset epilepsy associated with tuberous sclerosis
    Raffaella Cusmai
    Division of Neurology, Bambino Gesu Children s Hospital, Rome, Italy
    Epilepsy Behav 22:735-9. 2011
    ....
  6. doi request reprint Early control of seizures improves long-term outcome in children with tuberous sclerosis complex
    Roberta Bombardieri
    Department of Neurosciences, Pediatric Neurology Unit, Tor Vergata University, Via Montpellier 1, Rome 00133, Italy
    Eur J Paediatr Neurol 14:146-9. 2010
    ..Early control of seizures has a crucial role in preventing subsequent epileptic encephalopathy, and in reducing the cognitive/behavioural consequences of seizures, but does not guarantee for a normal mental outcome in children with TSC...
  7. doi request reprint Attention-deficit hyperactivity disorder (ADHD) and tuberous sclerosis complex
    Elisa D'Agati
    Department of Neuroscience, Pediatric Neurology Unit, Tor Vergata University of Rome, Via Montpellier 1, 00133 Rome, Italy
    J Child Neurol 24:1282-7. 2009
    ....
  8. doi request reprint The management of subependymal giant cell tumors in tuberous sclerosis: a clinician's perspective
    Romina Moavero
    Neuroscience Department, Pediatric Neurology Unit, Tor Vergata University of Rome, Rome, Italy
    Childs Nerv Syst 27:1203-10. 2011
    ....
  9. doi request reprint Rufinamide for the treatment of refractory epilepsy secondary to neuronal migration disorders
    Raffaella Cusmai
    Division of Neurology, Bambino Gesu Children s Hospital, IRCCS, Rome, Italy
    Epilepsy Res 108:542-6. 2014
    ..To evaluate the efficacy and tolerability of add-on rufinamide in children with refractory epilepsy symptomatic of neuronal migration disorders...
  10. doi request reprint Epilepsy secondary to tuberous sclerosis: lessons learned and current challenges
    Romina Moavero
    Department of Neuroscience, Pediatric Neurology Unit, Tor Vergata University of Rome, Via Montpellier 1, 00133, Rome, Italy
    Childs Nerv Syst 26:1495-504. 2010
    ..Dysregulated excitation probably has its roots in the disruption of GABAergic interneuron development. There is an age-dependent electroclinical expression of seizures, and epilepsy is often quite severe and unremitting...
  11. ncbi request reprint Pancreatic neuroendocrine tumor in a child with a tuberous sclerosis complex 2 (TSC2) mutation
    Roberta Bombardieri
    Neuroscience Department, Pediatric Neurology Unit, Tor Vergata University Hospital of Rome, Italy
    Endocr Pract 19:e124-8. 2013
    ..Pancreatic neuroendocrine tumors (PanNETs) are rare in children with tuberous sclerosis complex (TSC). The objective of this report is to describe a case of PanNET in a boy with TSC...
  12. doi request reprint mTOR inhibitors as a new therapeutic option for epilepsy
    Paolo Curatolo
    Child Neurology and Psychiatry Unit, Systems Medicine Department, Tor Vergata University Hospital, Rome, Italy
    Expert Rev Neurother 13:627-38. 2013
    ..The authors reviewed the current knowledge of mTOR overactivation in different forms of epilepsy, and discuss the potential clinical use of mTOR inhibitors...
  13. doi request reprint Attention deficit hyperactivity disorder in children with epilepsy
    Pasquale Parisi
    Department of Pediatrics La Sapienza University of Rome, Rome, Italy
    Brain Dev 32:10-6. 2010
    ..Treatment with psychotropic drugs can be initiated safely in most children with epilepsy and ADHD symptoms...
  14. doi request reprint Autism spectrum disorders in tuberous sclerosis: pathogenetic pathways and implications for treatment
    Paolo Curatolo
    Department of Neurosciences, Pediatric Neurology Unit, Tor Vergata University, Rome, Italy
    J Child Neurol 25:873-80. 2010
    ..A greater understanding of the pathogenetic mechanisms underlying autism in tuberous sclerosis could help in devising targeted and potentially more effective treatment strategies...
  15. ncbi request reprint Abnormal parieto-motor connectivity in Tuberous Sclerosis Complex
    Luigi D'Argenzio
    Paediatric Neurology and Psychiatry Unit, Neuroscience Department, Tor Vergata University, Rome, Italy
    Epilepsy Res 87:102-5. 2009
    ..Such altered connectivity might play a role in TSC epileptic phenotype...
  16. ncbi request reprint Ketogenic diet in early myoclonic encephalopathy due to non ketotic hyperglycinemia
    Raffaella Cusmai
    Neurology Unit, Bambino Gesu Children s Hospital, IRCCS, Rome, Italy
    Eur J Paediatr Neurol 16:509-13. 2012
    ..In our patients ketogenic diet, in association with standard pharmacological therapy, determined dramatic reduction of seizures and improved quality of life...
  17. doi request reprint Timing and clinical characteristics of topiramate-induced psychosis in a patient with epilepsy and tuberous sclerosis
    Augusto Pasini
    Department of Neuroscience, Unit of Child Neurology and Psychiatry, Tor Vergata University of Rome, Rome, Italy
    Clin Neuropharmacol 37:38-9. 2014
    ..We hypothesized that psychotic symptoms appeared a month after the topiramate introduction because of the slow topiramate titration and protective effect of carbamazepine. ..
  18. ncbi request reprint Pharmacotherapy of idiopathic generalized epilepsies
    Paolo Curatolo
    Tor Vergata University, Pediatric Neurology Unit, Department of Neurosciences, Rome, 00133, Italy
    Expert Opin Pharmacother 10:5-17. 2009
    ..Several new antiepileptic drugs (AEDs) have been studied in children with IGE...
  19. doi request reprint The neurobiology of attention deficit/hyperactivity disorder
    Paolo Curatolo
    Department of Neuroscience, Pediatric Neurology Unit, Tor Vergata University of Rome, Rome, Italy
    Eur J Paediatr Neurol 13:299-304. 2009
    ..Methylphenidate, as well as the catecholaminergic nonstimulant atomoxetine, are effective in improving ADHD symptoms...
  20. doi request reprint Syndromic autism: causes and pathogenetic pathways
    Arianna Benvenuto
    Department of Neuroscience, Pediatric Neurology Unit, Tor Vergata University, Via Montpellier 1, 00133, Rome, RM, Italy
    World J Pediatr 5:169-76. 2009
    ..This article aims to review the current understanding of the etiologies and the multiple pathogenetic pathways that are likely to lead to the autistic phenotype...
  21. pmc mTOR Inhibitors in Tuberous Sclerosis Complex
    Paolo Curatolo
    Pediatric Neurology Unit, Neuroscience Department, Tor Vergata University Hospital, Rome, Italy
    Curr Neuropharmacol 10:404-15. 2012
    ..This article will discuss the role of the mTOR pathway in TSC and review the pharmacokinetics, pharmacodynamics, clinical efficacy, and tolerability of mTOR inhibitors, along with their current place in clinical practice...